IDEAYA Biosciences, Inc. 10-K

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. Market Information Our common stock trades on the Nasdaq Global Select Market under the symbol “IDYA.” Stockholders As of March 14, 2022, we had 12 record holders of our common stock. Since many of our shares of common stock are held by brokers and other institutions on behalf of stockholders, we are unable to estimate the total number of stockholders represented by these record holders. Dividend Policy We have never declared or paid any cash dividends on our common stock and do not anticipate paying cash dividends in the foreseeable future. Securities Authorized for Issuance under Equity Compensation Plans Information about our equity compensation plans is incorporated by reference to Item 12 of Part III of this Annual Report on Form 10-K. Sale of Unregistered Securities None. Use of Proceeds from the Sale of Registered Securities Not applicable. Issuer Purchases of Equity Securities The following table summarizes repurchases of our common stock during fiscal year 2021: Period Total Number of Shares Purchased Average Price Paid Per Share Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs Maximum Number of Shares that May Yet be Repurchased Under the Plans or Programs December 2021 7,313 $ 0.82 — — Total 7,313 $ 0.82 — $ — All of the shares repurchased, as reflected in the table above, were repurchases of unvested shares of our common stock. Upon termination of employment of a person holding unvested shares, we are entitled to repurchase the unvested shares. Item 6. Reserved We have omitted this information in accordance with the elimination of Item 301 of Regulation S-K (Release No. 33-10890). 88